Skip to main content
Caplight Logo









Vortex Biosciences

Vortex Biosciences

Private
ManchesterHealthcare & Life Scienceshttps://vortexctc.ai/

Last Round

VC Round

Jun 22, 2023

Total Funding Raised

$2.42M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vortex Biosciences is a biotechnology company that develops and provides a liquid biopsy platform designed for the automated isolation of circulating tumor cells from whole blood for cancer diagnostics and research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

liquid biopsycirculating tumor cellsCTCsCTC isolationmicrofluidic technologylabel-free cell separationoncology researchmicrofluidic cartridgessample preparationnon-invasive diagnosticsbiotech equipmentlab-on-a-chipcell sortingpersonalized medicinerazor and blade modelResearch Use OnlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vortex Biosciences Comparables

Compare Vortex Biosciences with similar companies based on industry and business-model similarity.

Vortex Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cytotrait
90%
Cell Microsystems
84%
CelLBxHealth plc
83%

Vortex Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 22, 2023
VC RoundAug 16, 2022
DebtAug 16, 2022
VC RoundApr 25, 2019

Vortex Biosciences Investors

Notable investors and investment history

Vortex Biosciences investors
InvestorRounds
EMV CapitalDebt, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 63% MoM.

  • May 18, 2026

    Monthly visitors grew 121% MoM, from 217 to 479.

Vortex Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vortex Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vortex Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester
Employee Range4
Year Founded2012
Last FundingJun 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?